|
|
|
Insider
Information: |
Lenz Brian |
Relationship: |
|
City: |
Monmouth Junction |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
739,002 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,754,264 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
739,002 |
|
|
Total
Value |
$6,754,264 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
2
|
Stock
price went up :
|
2
|
2
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
-1.1%
|
105.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vioquest Pharmaceuticals |
VOQP |
CFO and Treasurer |
2008-01-14 |
15,000 |
2005-12-09 |
0 |
Premium* |
|
Arno therapeutics Inc |
ARNI |
Chief Financial Officer |
2008-09-08 |
4,000 |
2008-09-08 |
0 |
Premium* |
|
Cormedix Inc. |
CRMD |
CFO, TREASURER & SECRE... |
2011-12-14 |
17,000 |
2010-03-30 |
0 |
Premium* |
|
ADMA Biologics Inc |
ADMA |
|
2024-03-07 |
703,002 |
2013-10-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2022-12-09 |
4 |
B |
$2.86 |
$20,000 |
D/D |
6,993 |
1,034,825 |
0.01 |
% |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-02-25 |
4 |
D |
$3.42 |
$32,442 |
D/D |
(9,486) |
911,117 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-02-28 |
4 |
D |
$3.55 |
$17,750 |
D/D |
(5,000) |
906,117 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
135,175 |
1,041,292 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-03-07 |
4 |
D |
$3.40 |
$57,681 |
D/D |
(16,965) |
1,024,327 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-06-30 |
4 |
D |
$3.69 |
$56,339 |
D/D |
(15,268) |
993,591 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-08-15 |
4 |
OE |
$1.67 |
$2,514,363 |
D/D |
809,262 |
1,591,275 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-08-15 |
4 |
S |
$4.60 |
$972,730 |
D/D |
(211,578) |
782,013 |
0 |
% |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-08-15 |
4 |
D |
$4.61 |
$2,909,270 |
D/D |
(631,078) |
960,197 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-08-16 |
4 |
S |
$4.45 |
$793,400 |
D/D |
(178,184) |
782,013 |
0 |
% |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-09-30 |
4 |
D |
$3.58 |
$54,659 |
D/D |
(15,268) |
766,744 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2023-12-31 |
4 |
D |
$4.52 |
$76,424 |
D/D |
(16,908) |
749,836 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2024-02-25 |
4 |
D |
$5.26 |
$43,432 |
D/D |
(8,257) |
741,579 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2024-02-29 |
4 |
D |
$5.36 |
$26,452 |
D/D |
(4,935) |
736,644 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2024-03-06 |
4 |
D |
$6.12 |
$102,063 |
D/D |
(16,677) |
719,967 |
0 |
- |
|
ADMA |
ADMA Biologics Inc |
EVP, CFO |
|
2024-03-07 |
4 |
D |
$6.16 |
$104,504 |
D/D |
(16,965) |
703,002 |
0 |
- |
|
VOQP |
Vioquest Pharmaceuticals |
officerTitle |
|
2005-12-09 |
4 |
B |
$0.80 |
$4,000 |
D/D |
5,000 |
5,000 |
2.66 |
- |
|
ADMA |
ADMA Biologics Inc |
VP, CFO |
|
2017-11-09 |
4 |
B |
$2.15 |
$13,975 |
D/D |
6,500 |
15,000 |
2.74 |
- |
|
ADMA |
ADMA Biologics Inc |
VP, CFO |
|
2018-06-08 |
4 |
B |
$4.78 |
$23,900 |
D/D |
5,000 |
20,000 |
2.74 |
- |
|
44 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|